Skip to main content

Want a detailed portfolio tracker?

Channel Therapeutics (PTHS) P/E (2024 - 2026)

Channel Therapeutics (PTHS) P/E from Feb 16, 2024 to Jul 21, 2026. The TTM Channel Therapeutics (PTHS) P/E is -0.69. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Channel Therapeutics (PTHS)

YearP/EChange
2026-0.69-13.03%
2025-0.79+67.43%
2024-0.47N/A

Comparison Channel Therapeutics (PTHS) P/E with competitors

Channel Therapeutics (PTHS) P/E is -0.69.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.25%
NBYStablecoin Development Corp0.00-100.62%
ENLVEnlivex Ltd0.07-110.85%
FGENFibroGen Inc0.24-134.83%
CHRSCoherus Biosciences Inc0.85-223.13%
FBIOFortress Biotech Inc0.95-237.72%
ORMPOramed Pharmaceuticals Inc1.50-318.11%
AGENAgenus Inc3.01-536.73%
INVAInnoviva Inc3.15-557.69%
VXRTVaxart Inc3.55-615.11%
CRMDCorMedix Inc3.63-626.53%
CVACCureVac N.V.4.45-745.12%
GLPGGalapagos NV4.86-805.08%
SRPTSarepta Therapeutics Inc4.88-808.45%
ABEOAbeona Therapeutics Inc5.39-881.79%
ABUSArbutus Biopharma Corp5.60-911.99%
ZVRAZevra Therapeutics Inc5.89-954.31%
SPROSpero Therapeutics Inc6.23-1003.82%
CGENCompugen Ltd6.31-1016.23%
RIGLRigel Pharmaceuticals6.87-1097.22%
SLXNSilexion Therapeutics Corp7.30-1158.75%
OMEROmeros Corporation9.26-1443.55%
AUPHAurinia Pharmaceuticals Inc9.58-1490.89%
PLXProtalix BioTherapeutics Inc10.89-1680.42%
ACADAcadia Pharmaceuticals Inc11.73-1801.95%
TBPHTheravance Biopharma Inc12.26-1879.39%
ADMAAdma Biologics Inc12.42-1902.02%
HRMYHarmony Biosciences Holdings Inc13.82-2105.48%
SABSSAB Biotherapeutics Inc14.14-2151.34%
NAGENiagen Bioscience Inc14.82-2250.29%
INCYIncyte Corp15.82-2396.05%
REGNRegeneron Pharmaceuticals Inc15.86-2401.00%
PBYIPuma Biotechnology Inc17.32-2612.72%
CPRXCatalyst Pharmaceuticals Inc17.44-2630.66%
EXELExelixis Inc17.54-2644.98%
TGTXTG Therapeutics Inc18.97-2852.21%
MDXGMimedx Group Inc20.55-3082.42%
XOMAXOMA Royalty Corp22.87-3419.49%
ARGXArgen X SE24.30-3626.03%
CTMXCytomX Therapeutics Inc24.82-3701.94%
XOMAOXOMA Royalty Corp25.34-3777.94%
HALOHalozyme Therapeutics Inc25.62-3818.41%
XOMAPXOMA Royalty Corp25.67-3825.15%
VRTXVertex Pharmaceuticals Inc27.99-4162.49%
RPRXRoyalty Pharma plc - Class A28.69-4263.03%
SLNOSoleno Therapeutics Inc29.02-4310.59%
ASNDAscendis Pharma A/S30.09-4465.90%
LGNDLigand Pharmaceuticals Inc - Class B37.91-5601.65%
APLSApellis Pharmaceuticals Inc39.02-5762.61%
BMRNBiomarin Pharmaceutical Inc42.21-6225.62%
KRYSKrystal Biotech Inc45.34-6680.07%
ONCBeiGene Ltd69.54-10191.45%
PHARPharming Group N.V.75.03-10987.43%
TECHBio-Techne Corp101.96-14895.82%
VCELVericel Corp109.92-16051.37%
ALNYAlnylam Pharmaceuticals Inc117.96-17218.65%
GMABGenmab140.29-20458.47%
TLXTelix Pharmaceuticals Ltd162.15-23631.01%
CORTCorcept Therapeutics Inc212.86-30989.09%